Hence, NAT2 genotyping is warranted before the starting of the administration of anti-tuberculosis drug therapy, this will ultimately help the clinicians to personalize and optimize the treatments régimes, making them therapeutically more efficient while simultaneously minimizing the side effects associated with the use of these drugs. Here, NAT2 is linked to tuberculosis.